Pixel Source Trademark Services – Trademark Portfolio

Entity Type: 03

Pixel Source Trademark Services holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 4 filings in this category. Currently, 2 trademarks are registered. Notable registered marks include ADITOX and NADLIFT. The owner is based in North Bay Village, FL.

#409

1666 79th Street Causeway

North Bay Village, FL 33141

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

NADLIFT
NADLIFT
Registered 2022
NUSORBA
NUSORBA
Abandoned 2022
ADITOX
ADITOX
Registered 2022
ANAGEN+
ANAGEN+
Abandoned 2022

Trademark Classifications

Pixel Source Trademark Services's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (4 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Pixel Source Trademark Services have?

Pixel Source Trademark Services has 4 U.S. trademarks filed with the USPTO. Of these, 2 registered, 2 abandoned.

What trademark classes does Pixel Source Trademark Services file in?

Pixel Source Trademark Services files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Pixel Source Trademark Services's most well-known trademarks?

Pixel Source Trademark Services's registered trademark portfolio includes well-known marks such as ADITOX and NADLIFT. These are among 2 currently registered trademarks in the portfolio.

What is Pixel Source Trademark Services's trademark registration success rate?

Pixel Source Trademark Services has a 50% trademark registration rate, with 2 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.